## Section 29: Buyside Due Diligence - Operating Performance

**Revenue:**

[FACT] FY2024 revenue from continuing operations (manufacturing) grew by 10.5% to S$114.9 million from S$103.9 million in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] The higher topline was due to higher order volumes from existing customers, as well as new projects secured in the biomedical and consumer segments. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] While China operations contributed 27.9% of total manufacturing revenue, a reduction of 7.1 percentage points ("ppt") from FY2023, the Singapore and Malaysia operations gained 20.9 ppt to S$46.2 million and 24.9 ppt to S$36.6 million, respectively. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] Singapore operations sales improved 20.9% to S$46.2 million in FY2024 from S$38.2 million in FY2023, mainly due to higher sales in the medical and consumer segments. | [SOURCE: Fu Yu 24 AR_m.md, page 8]
[FACT] Malaysia segment revenue contribution improved 24.9% to S$36.6 million in FY2024 from S$29.3 million in FY2023, mainly due to higher demand for medical and consumer products. | [SOURCE: Fu Yu 24 AR_m.md, page 8]
[FACT] China operations revenue contribution declined 11.8% to S$32.1 million in FY2024 compared to S$36.4 million in FY2023 due to slower business activities. | [SOURCE: Fu Yu 24 AR_m.md, page 8]
[FACT] 1H2024 Group-wide revenue rose 78.0%, propelled by higher sales for both manufacturing and supply chain management segments. | [SOURCE: Fuyu Pres H124_m.md, page 5]
[FACT] 1H2024 manufacturing revenue rose to S$54.8M (1H2023: S$52.6M). | [SOURCE: Fuyu Pres H124_m.md, page 5]
[FACT] Higher sales in Singapore and Malaysia, partially offset by lower contributions from China in 1H2024. | [SOURCE: Fuyu Pres H124_m.md, page 5]
[FACT] Supply chain management services posted revenue of S$72.0M in 1H2024 (1H2023: S$18.6M). | [SOURCE: Fuyu Pres H124_m.md, page 5]
[FACT] In 1H2024, Singapore manufacturing revenue was S$21.0M (1H2023: S$19.7M), a 6.6% increase. | [SOURCE: Fuyu Pres H124_m.md, page 5]
[FACT] In 1H2024, Malaysia manufacturing revenue was S$17.8M (1H2023: S$12.8M), a 39.1% increase. | [SOURCE: Fuyu Pres H124_m.md, page 5]
[FACT] In 1H2024, China manufacturing revenue was S$16.0M (1H2023: S$20.1M), a 20.4% decrease. | [SOURCE: Fuyu Pres H124_m.md, page 5]


**Profitability:**

[FACT] FY2024 gross profit increased 27.5% to S$15.5 million compared to FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] FY2024 gross profit margin improved to 13.5% from 11.7% in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] Earnings Before Interest, Taxation, Depreciation, and Amortisation (EBITDA) increased more than 14-fold to S$8.5 million from S$0.6 million in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] FY2024 net loss from continuing operations narrowed sharply to S$1.2 million from S$7.6 million in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] Excluding a one-off non-cash impairment, net loss for continuing operations for FY2024 would have been S$0.6 million. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] Group-wide gross profit in FY2024 increased 27.8% to S$17.0 million from S$13.3 million in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 7]
[FACT] Overall gross profit margin increased to 8.9% in FY2024 compared to 7.0% in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 7]
[FACT] Gross profit from the manufacturing segment increased 28.1% to S$15.5 million in FY2024 from S$12.1 million in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 7]
[FACT] 1H2024 gross profit rose 32.8% to S$8.5M from S$6.4M in 1H2023. | [SOURCE: Fuyu Pres H124_m.md, page 6]
[FACT] GPM for 1H2024 stood at 6.7% (1H2023: 9.0%) due to change in revenue mix. | [SOURCE: Fuyu Pres H124_m.md, page 6]
[FACT] Recorded net profit of S$0.1M in 1H2024, a reversal from S$3.9 million net loss in 1H2023. | [SOURCE: Fuyu Pres H124_m.md, page 6]
[FACT] S$0.8M operating profit in 1H2024 (1H2023: S$3.8M operating loss). | [SOURCE: Fuyu Pres H124_m.md, page 6]
[FACT] S$0.6M net profit from supply chain management services in 1H2024 (1H2023: S$0.2M net loss) offsets S$0.5M net loss in manufacturing business in 1H2024 (1H2023: S$3.7M net loss). | [SOURCE: Fuyu Pres H124_m.md, page 6]


**Other Key Metrics:**

[FACT] FY2024 net operating cash inflow was S$3.6 million compared to net operating cash outflow of S$4.5 million in FY2023. | [SOURCE: Fu Yu 24 AR_m.md, page 4]
[FACT] As at 31 December 2024, the Group had net cash of S$55.5 million. | [SOURCE: Fu Yu 24 AR_m.md, page 7]
[FACT]  As at 31 December 2024, shareholders' equity stood at S$136.2 million, equivalent to a net asset value of 17.87 cents per share. | [SOURCE: Fu Yu 24 AR_m.md, page 7]
[FACT] 1H2024 recorded CAPEX of S$3.9 million mainly for purchase of new machineries in Singapore. | [SOURCE: Fuyu Pres H124_m.md, page 8]
[FACT] As of 30 June 2024, cash and bank balance was S$59.1M.  | [SOURCE: Fuyu Pres H124_m.md, page 8]
[FACT] As of 30 June 2024, total assets were S$180.1M. | [SOURCE: Fuyu Pres H124_m.md, page 8]
[FACT] As of 30 June 2024, total liabilities were S$40.3M. | [SOURCE: Fuyu Pres H124_m.md, page 8]

**Note:**  Some data points are presented in multiple places within the provided documents, with slight variations.  This response aims to capture all relevant information, acknowledging these minor inconsistencies.  The page numbers refer to the provided document's internal pagination.
